// App-Quantinova.ai

: Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis Mechanism Comparison on the Basis of Gene Expression Profiles

Researchers

Presenter

  • F. Xu

Principal Investigators

  • N. Tanabe

  • D. Kinose

  • D. M. Vasilescu

  • J. E. McDonough

  • K. Ikezoe

  • K. Ng

  • S. Verleden

  • B. Vanaudenaerde

  • J. Verschakelen

  • J. D. Cooper

  • M. E. Lenburg

  • A. Spira

  • J. C. Hogg

Medical Centers

  • Pathology and Laboratory Medicine, University of BC, Vancouver, BC, Canada

  • Department of Respiratory Medicine, Kumamoto University, Kumamoto, Japan.

  • Kyoto University, Kyoto, Japan

  • Centre for Heart Lung Innovation,Medicine, Vancouver BC, Canada

  • Pneumology, KU Leuven, Leuven, BC, Canada,

  • Centre for Heart and Lung Innovation, UBC, VANCOUVER, BC, Canada,

  • The Francis Crick Institute, London, United Kingdom

  • Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium

  • Leuven Lung Transplant Unit, KU Leuven and UZ Gasthuisberg, Leuven, Belgium,

  • Univ of Pennsylvania Medical Ctr, Philadelphia, PA, United States,

  • Boston University School of Medicine, Boston, MA, United States

  • Boston University Medical Campus, Boston, MA, United States,

  • Research Center, St Pauls Hospital, Vancouver, BC, Canada,

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

  • Idiopathic pulmonary fibrosis

  • Pulmonary fibrosis

Biomarkers

  • Cluster of Differentiation 4

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

  • Pyruvate dehydrogenase kinase 1

  • Interferon-gamma

  • Regulatory T cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved